Lung cancer is classified into non-small cell and small cell types, influencing treatment strategies and prognosis. Advances in targeted therapies, immunotherapy, and minimally invasive surgeries have ...

Breast cancer is the most common cancer among women, making up 30% of all new cases each year. Knowledge is power when it comes to detection and prevention of this disease: Genetic testing can play an ...

Whitney Maxwell, MS, CGC, stands at the helm of the Inherited Cancer Research Shared Resource at Huntsman Cancer Institute at the University of Utah, overseeing a dynamic team of genetic counselors, ...

Breast cancer is a complex disease with numerous classifications. Understanding risk factors such as age, family history, genetic mutations such as breast cancer gene 1/breast cancer gene 2 ...

Pancreatic cancer is mostly pancreatic ductal adenocarcinoma, with late-stage detection due to non-specific symptoms like jaundice and abdominal pain. Diagnosis involves imaging tests, biopsies, and ...

Marcy Richardson from Ambry Genetics discusses the importance of a new study that assessed the functional impact of thousands of BRCA2 variants, identifying those that may increase cancer risk. What ...

Tumors can develop anywhere cells are present (i.e., essentially anywhere in the body), and they are classified as benign or ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. INDIANAPOLIS — For millennials and Gen Z, ...

We are at a transformative moment in oncology. Remarkable advancements have led to the identification of biomarkers that can predict treatment response, tests that can detect cancer risk before ...

Colorectal cancer is the third most commonly diagnosed cancer worldwide and the second leading cause of cancer death, yet one of its deadliest features remains poorly understood: how tumor cells break ...

Personalized treatment strategies are increasingly important in managing lung cancer brain metastases, incorporating targeted therapies and immunotherapies. Stereotactic radiosurgery and whole-brain ...

Myriad Genetics, Inc. announced that its MyRisk® Hereditary Cancer Test with RiskScore® was recognized in the American Journal of Human Genetics as one of the top 10 significant advances in genomic ...